Barr Settles With Sandoz For $22.5M Over Blood Thinner

Law360, New York (June 12, 2006, 12:00 AM EDT) -- Bringing a long-running legal battle to an end, Barr Laboratories Inc. has agreed to a $22.5 million settlement deal with Invamed Inc. and Apothecon Inc. over the raw material source for the blood thinner Warfarin Sodium.

Under the terms of the deal, Barr will fork over a one-time payment of $22.5 million to Invamed and Apothecon, both of which are owned by Sandoz Inc., a unit of Novartis. The payment, totaling approximately 13 cents per share, will be reported in Barr’s results for the quarter ending...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.